Found: 4
Select item for more details and to access through your institution.
The anti‐mitotic agents PTC‐028 and PTC596 display potent activity in pre‐clinical models of multiple myeloma but challenge the role of BMI‐1 as an essential tumour gene.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 877, doi. 10.1111/bjh.16595
- By:
- Publication type:
- Article
Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01943
- By:
- Publication type:
- Article
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 261, doi. 10.3390/cancers11020261
- By:
- Publication type:
- Article
Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0281-2
- By:
- Publication type:
- Article